查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞和基因治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、服務、規模、服務提供者、最終用戶和地理位置
市場調查報告書
商品編碼
1558413

細胞和基因治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、服務、規模、服務提供者、最終用戶和地理位置

Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 232 Pages | 訂單完成後即時交付

價格

細胞和基因治療市場預計將從2023年的44.850億美元成長到2031年的280.5039億美元；預計2023年至2031年複合年成長率為25.8%。

有助於細胞和基因治療市場分析的關鍵部分是服務、規模、服務提供者和最終用戶。

細胞和基因治療市場，按類型分類，細胞和基因治療市場分為細胞治療和基因治療。細胞療法領域在 2023 年佔據了更大的市場佔有率。細胞療法在引入患者之前在體外形成或修飾細胞。這些細胞可能來自患者（自體細胞）或捐贈者（同種異體細胞）。細胞療法領域的成長歸因於進入市場的產品數量不斷增加、細胞療法在治療自體免疫疾病、癌症和傳染病方面的潛在應用以及大量正在進行的臨床試驗。

細胞和基因治療市場按服務細分為製程開發、cGMP 製造、監管服務、生物測定服務。到 2023 年，製程開發領域將佔據更大的市場佔有率。憑藉這些進步，細胞和基因療法開發商提供了開發穩健且可擴展的製造流程、確保高品質產品一致性以及最佳化特定治療標靶的遞送方法的專業知識。

按類型分類，市場分為通風型和非通風型。到 2023 年，通風部分將佔據更大的市場佔有率。

細胞及基因治療市場，依規模分類，市場分為預商業/研發製造、商業規模製造。 2023 年，預商業/研發製造領域將佔據更大的市場佔有率。

細胞和基因治療市場，依服務提供者分類，市場分為CDMO、CMO。到 2023 年，CDMO 細分市場將佔據更大的市場佔有率。

細胞和基因治療市場，依最終用戶分類，市場分為合約研究組織、製藥和生物製藥公司、學術和研究機構。製藥和生物製藥公司細分市場在 2023 年佔據主導地位。

細胞和基因治療市場報告的範圍涵蓋北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國） 、日本、印度、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。從收入來看，北美在2023年佔據最大的市場佔有率。該國擁有大量患者，這對於開發這些治療方法的公司來說是一個有吸引力的市場。中國有幾家公司正在致力於癌症和遺傳性疾病等疾病的創新療法，並且中國在基因療法的研究和開發方面投入了大量資金。 2003年，中國成為第一個批准基因治療的國家；從那時起，細胞和基因療法的發展在全球迅速發展，其治療潛力大幅上升。中華人民共和國政府進行了多項監管改革，以促進細胞和基因療法的規範發展。此外，各細分市場的各種市場領導者的存在也有助於市場擴張，這尤其有助於細胞和基因治療市場規模的擴大。

歐盟 (EU)、經濟合作暨發展組織 (OECD) 和國家醫學圖書館 (NLM) 是在準備細胞和基因治療市場報告時參考的幾個關鍵的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：細胞與基因療法市場格局

  • 概述
  • PEST分析

第 5 章：細胞與基因治療市場 - 主要市場動態

  • 細胞和基因治療市場 - 主要市場動態
  • 市場促進因素
    • 細胞和基因療法批准數量的增加
    • 外包細胞與基因治療製造迅速普及
  • 市場限制
    • 細胞和基因療法製造成本高昂
  • 市場機會
    • 公司的策略舉措
  • 未來趨勢
    • 細胞和基因治療製造服務的自動化
  • 促進因素和限制的影響：

第 6 章：細胞與基因治療市場 - 全球市場分析

  • 細胞和基因治療市場收入，2021-2031
  • 細胞和基因治療市場預測分析

第 7 章：細胞和基因治療市場分析 - 按類型

  • 細胞療法
  • 基因治療

第 8 章：細胞和基因治療市場分析 - 按服務

  • 製程開發
  • cGMP 製造
  • 監管服務
  • 生物測定服務

第 9 章：細胞和基因治療市場分析 - 按規模

  • 預商業/研發製造
  • 商業規模製造

第 10 章：細胞和基因治療市場分析 - 按服務提供者

  • CDMO
  • 首席行銷長

第 11 章：細胞和基因治療市場分析 - 按最終用戶

  • 合約研究組織
  • 製藥和生物製藥公司
  • 學術及研究機構

第 12 章：細胞與基因治療市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 13 章：產業格局

  • 概述
  • 細胞和基因治療市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Charles River Laboratories International Inc
  • Cell and Gene Therapy Catapult
  • Lonza Group AG
  • WuXi AppTec Co Ltd
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • F. Hoffmann-La Roche Ltd
  • Catalent Inc
  • Lotte Corp

第 15 章：附錄

Product Code: TIPRE00020854

The cell and gene therapy market is expected to grow from US$ 4,485.00 million in 2023 to US$ 28,050.39 million by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031.

Key segments that contributed to the derivation of the cell and gene therapy market analysis are services, scale, service providers, and end user.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023. Cell therapy helps treat disorders and diseases by restoring or changing certain groups of cells or providing cells to carry therapy through the body. Cell therapy forms or modifies cells outside the body before introducing into the patient. The cells might derive from the patient (autologous cells) or a donor (allogeneic cells). The growth of the cell therapy segment is attributed to the increasing number of products entering the market, the potential application of cell therapies in treating autoimmune diseases, cancer, and infectious diseases, and the high number of ongoing clinical trials.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023. The cell and gene therapy market is witnessing rapid growth driven by technological advancements, particularly in manufacturing and delivery services. With such advancements, cell and gene therapy developers offer expertise in developing robust and scalable manufacturing processes, ensuring high-quality product consistency, and optimizing delivery methods for specific therapeutic targets.

By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

The scope of the cell and gene therapy market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America accounted for the largest market share in 2023. On the other hand, Asia Pacific region accounted for the fastest-growing global cell and gene therapy market in 2023. China is making progress in gene and cell therapy. The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. In addition, the presence of various market leaders operating in the segments is contributing to the market expansion, which contribute notably to the expansion of cell and gene therapy market size.

European Union (EU), Organisation for Economic Co-operation and Development (OECD), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the cell and gene therapy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Cell and Gene Therapy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Cell and Gene Therapy Market - Key Market Dynamics

  • 5.1 Cell and Gene Therapy Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
    • 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Companies
  • 5.5 Future Trends
    • 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market - Global Market Analysis

  • 6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • 6.2 Cell and Gene Therapy Market Forecast Analysis

7. Cell and Gene Therapy Market Analysis - by Type

  • 7.1 Cell Therapy
    • 7.1.1 Overview
    • 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Gene Therapy
    • 7.2.1 Overview
    • 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell and Gene Therapy Market Analysis - by Services

  • 8.1 Process Development
    • 8.1.1 Overview
    • 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 cGMP Manufacturing
    • 8.2.1 Overview
    • 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regulatory Services
    • 8.3.1 Overview
    • 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Bioassay Services
    • 8.4.1 Overview
    • 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell and Gene Therapy Market Analysis - by Scale

  • 9.1 Pre Commercial/R and D Manufacturing
    • 9.1.1 Overview
    • 9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Commercial Scale Manufacturing
    • 9.2.1 Overview
    • 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell and Gene Therapy Market Analysis - by Service Providers

  • 10.1 CDMOs
    • 10.1.1 Overview
    • 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 CMOs
    • 10.2.1 Overview
    • 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Cell and Gene Therapy Market Analysis - by End User

  • 11.1 Contract Research Organizations
    • 11.1.1 Overview
    • 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Pharmaceutical and Biopharmaceutical Companies
    • 11.2.1 Overview
    • 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Academic and Research Institutes
    • 11.3.1 Overview
    • 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

  • 12.1 Overview
  • 12.2 North America
    • 12.2.1 North America Cell and Gene Therapy Market Overview
    • 12.2.2 North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
      • 12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
        • 12.2.3.1.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
        • 12.2.3.1.2 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
    • 12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
      • 12.2.4.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
    • 12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
      • 12.2.5.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
    • 12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
      • 12.2.6.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
    • 12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
      • 12.2.7.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
    • 12.2.8 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.2.8.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.2.8.2 United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
        • 12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
        • 12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
      • 12.2.8.3 Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
        • 12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
        • 12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
      • 12.2.8.4 Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
        • 12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
        • 12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
  • 12.3 Europe
    • 12.3.1 Europe Cell and Gene Therapy Market Overview
    • 12.3.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
      • 12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
        • 12.3.3.1.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
        • 12.3.3.1.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
    • 12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
      • 12.3.4.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
    • 12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
      • 12.3.5.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
    • 12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
      • 12.3.6.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
    • 12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.7.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
    • 12.3.8 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.3.8.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.3.8.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.8.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.8.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.8.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.8.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
      • 12.3.8.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
        • 12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
        • 12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
  • 12.4 Asia Pacific
    • 12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
    • 12.4.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
      • 12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
        • 12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
        • 12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
    • 12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
      • 12.4.4.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
    • 12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
      • 12.4.5.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
    • 12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
      • 12.4.6.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
    • 12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.7.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
    • 12.4.8 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.4.8.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.4.8.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.8.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.8.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.8.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.8.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
      • 12.4.8.7 Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
        • 12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
        • 12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
  • 12.5 Middle East and Africa
    • 12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
    • 12.5.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
      • 12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
        • 12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
        • 12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
    • 12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
      • 12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
    • 12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
      • 12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
    • 12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
      • 12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
    • 12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
      • 12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
    • 12.5.8 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.5.8.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
        • 12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
        • 12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
      • 12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
        • 12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
        • 12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
      • 12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
        • 12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
        • 12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
      • 12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
        • 12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
        • 12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
  • 12.6 South and Central America
    • 12.6.1 South and Central America Cell and Gene Therapy Market Overview
    • 12.6.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
      • 12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
        • 12.6.3.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
        • 12.6.3.1.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
    • 12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
      • 12.6.4.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
    • 12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
      • 12.6.5.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
    • 12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
      • 12.6.6.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
    • 12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
      • 12.6.7.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
    • 12.6.8 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.6.8.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.6.8.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
        • 12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
        • 12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
      • 12.6.8.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
        • 12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
        • 12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
      • 12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
        • 12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
        • 12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
        • 12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Cell and Gene Therapy Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Thermo Fisher Scientific Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Merck KGaA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Charles River Laboratories International Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cell and Gene Therapy Catapult
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Lonza Group AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 WuXi AppTec Co Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Takara Bio Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 FUJIFILM Holdings Corp
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 F. Hoffmann-La Roche Ltd
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Catalent Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Lotte Corp
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Cell and Gene Therapy Market Segmentation
  • Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
  • Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
  • Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
  • Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
  • Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
  • Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 11. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 12. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 13. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 14. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 15. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 16. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 17. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 18. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 19. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 20. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 21. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 22. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 23. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 24. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 25. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 26. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 27. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 28. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 29. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 30. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 31. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 32. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 34. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 35. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 36. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 37. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 38. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 39. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 40. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 41. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 42. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 43. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 44. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 45. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 46. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 47. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 48. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 49. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 50. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 51. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 52. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 53. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 54. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 55. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 56. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 57. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 58. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 59. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 60. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 61. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 62. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 63. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 64. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 65. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 66. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 67. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 68. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 69. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 70. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 71. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 72. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 73. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 74. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 75. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 76. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 77. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 78. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 79. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 80. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 81. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 82. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 83. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 84. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 85. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 86. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 87. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 88. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 89. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 91. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 92. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 93. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 94. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 95. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 96. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 97. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 98. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 99. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 100. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 101. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 102. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 103. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 104. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 105. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 106. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 107. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 108. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 109. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 110. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 111. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 112. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 113. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 114. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 115. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 116. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 117. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 118. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 119. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 120. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 121. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 122. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 123. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 124. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 125. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 126. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 127. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 128. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 129. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 130. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 131. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 132. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 133. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 134. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 135. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 136. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 137. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 138. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 139. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 140. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 141. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 142. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 143. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 144. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 145. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 146. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 147. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 148. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 149. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 150. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 151. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 152. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 153. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 154. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 155. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 156. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 157. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 158. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 159. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 160. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 161. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 162. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 163. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 164. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 165. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 166. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 167. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 168. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 169. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 170. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 171. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 172. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 173. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 174. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 175. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 176. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 177. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 178. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 179. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 180. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 181. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 182. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 183. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 184. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 185. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 186. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 187. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 188. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 189. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 190. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 191. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 192. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 193. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 194. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 195. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 196. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 197. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 198. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 199. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 200. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 201. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 202. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 203. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 204. Recent Organic Growth Strategies in Cell and Gene Therapy Market
  • Table 205. Recent Inorganic Growth Strategies in the Tympanostomy products Market

List Of Figures

  • Figure 1. Cell and Gene Therapy Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
  • Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
  • Figure 14. Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
  • Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
  • Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Cell and Gene Therapy Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 24. North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. North America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
  • Figure 26. North America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
  • Figure 27. North America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
  • Figure 28. North America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
  • Figure 29. North America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 30. United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Europe: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
  • Figure 35. Europe: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
  • Figure 36. Europe: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
  • Figure 37. Europe: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
  • Figure 38. Europe: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
  • Figure 39. Europe: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 40. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
  • Figure 48. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
  • Figure 49. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
  • Figure 50. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
  • Figure 51. Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
  • Figure 52. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 53. China: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. India: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
  • Figure 61. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
  • Figure 62. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
  • Figure 63. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
  • Figure 64. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
  • Figure 65. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 66. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 68. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 69. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. South and Central America: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
  • Figure 72. South and Central America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
  • Figure 73. South and Central America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
  • Figure 74. South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
  • Figure 75. South and Central America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
  • Figure 76. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 77. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 78. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 79. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 80. Growth Strategies in Cell and Gene Therapy Market